Participant flow42

How many started, completed or left each group, period by period.

1 to 20 of 42

Period	Milestone	Group	Participants
IR Treatment	STARTED	Placebo	148
IR Treatment	STARTED	Tapentadol 50 mg	151
IR Treatment	STARTED	Tapentadol 75 mg	154
IR Treatment	STARTED	Oxycodone	143
IR Treatment	STARTED	Placebo ER	0
IR Treatment	STARTED	Tapentadol ER	0
IR Treatment	STARTED	Oxycodone CR	0
IR Treatment	COMPLETED	Placebo	132
IR Treatment	COMPLETED	Tapentadol 50 mg	134
IR Treatment	COMPLETED	Tapentadol 75 mg	126
IR Treatment	COMPLETED	Oxycodone	100
IR Treatment	COMPLETED	Placebo ER	0
IR Treatment	COMPLETED	Tapentadol ER	0
IR Treatment	COMPLETED	Oxycodone CR	0
IR Treatment	NOT COMPLETED	Placebo	16
IR Treatment	NOT COMPLETED	Tapentadol 50 mg	17
IR Treatment	NOT COMPLETED	Tapentadol 75 mg	28
IR Treatment	NOT COMPLETED	Oxycodone	43
IR Treatment	NOT COMPLETED	Placebo ER	0
IR Treatment	NOT COMPLETED	Tapentadol ER	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00784277/flow